Journal
HUMAN MOLECULAR GENETICS
Volume 21, Issue 17, Pages 3806-3814Publisher
OXFORD UNIV PRESS
DOI: 10.1093/hmg/dds208
Keywords
-
Funding
- Wellcome Trust [077224, 091580]
- Medical Research Council, UK [G0800401]
- Action Medical Research in association with the Henry Smith Charity
- R S MacDonald Charitable Trust [SP4443]
- Rett Syndrome Research Trust [82561]
- MRC [G0800401] Funding Source: UKRI
- Medical Research Council [G0800401] Funding Source: researchfish
Ask authors/readers for more resources
Rett Syndrome is a neurological disorder caused by mutations in the X-linked MECP2 gene. Mouse models where Mecp2 is inactivated or mutated recapitulate several features of the disorder and have demonstrated a requirement for the protein to ensure brain function in adult mice. We deleted the Mecp2 gene in approximate to 80 of brain cells at three postnatal ages to determine whether the need for MeCP2 varies with age. Inactivation at all three time points induced Rett-like phenotypes and caused premature death of the animals. We find two threshold ages beyond which the requirement for MeCP2 markedly increases in stringency. The earlier threshold (814 weeks), when inactivated mice develop symptoms, represents early adulthood in the mouse and coincides with the period when Mecp2-null mice exhibit terminal symptoms. Unexpectedly, we identified a later age threshold (3045 weeks) beyond which an 80 reduction in MeCP2 is incompatible with life. This finding suggests an enhanced role for MeCP2 in the aging brain.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available